Senegin IICAS# 34366-31-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 34366-31-9 | SDF | Download SDF |
| PubChem ID | 11953920 | Appearance | Powder |
| Formula | C70H104O32 | M.Wt | 1457.6 |
| Type of Compound | Oligosaccharide Esters | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2S,3R,4S,4aR,6aR,6bR,8aS,12aS,14aR,14bR)-8a-[(2S,3R,4S,5R,6R)-3-[(2S,3R,4S,5R,6S)-5-[(2S,3R,4R,5R)-3,4-dihydroxy-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-5-[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]oxy-4-hydroxy-6-methyloxan-2-yl]oxycarbonyl-2-hydroxy-6b-(hydroxymethyl)-4,6a,11,11,14b-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid | ||
| SMILES | CC1C(C(C(C(O1)OC2C(C(C(OC2OC(=O)C34CCC(CC3C5=CCC6C(C5(CC4)CO)(CCC7C6(CC(C(C7(C)C(=O)O)OC8C(C(C(C(O8)CO)O)O)O)O)C)C)(C)C)C)OC(=O)C=CC9=CC(=C(C=C9)OC)OC)O)O)O)OC1C(C(C(CO1)OC1C(C(C(C(O1)CO)O)O)O)O)O | ||
| Standard InChIKey | MNXFXXWQAAMVMW-JEIATDTDSA-N | ||
| Standard InChI | InChI=1S/C70H104O32/c1-29-54(99-58-49(82)45(78)39(27-92-58)97-60-50(83)46(79)43(76)37(25-71)95-60)48(81)52(85)59(93-29)100-56-53(86)55(98-42(75)15-11-31-10-13-35(90-8)36(22-31)91-9)30(2)94-62(56)102-64(89)69-19-18-65(3,4)23-33(69)32-12-14-40-66(5)24-34(74)57(101-61-51(84)47(80)44(77)38(26-72)96-61)68(7,63(87)88)41(66)16-17-67(40,6)70(32,28-73)21-20-69/h10-13,15,22,29-30,33-34,37-41,43-62,71-74,76-86H,14,16-21,23-28H2,1-9H3,(H,87,88)/b15-11+/t29-,30+,33-,34-,37+,38+,39+,40+,41+,43-,44+,45-,46-,47-,48-,49+,50+,51+,52+,53-,54-,55-,56+,57-,58-,59-,60-,61-,62-,66+,67+,68-,69-,70-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Senegin II Dilution Calculator
Senegin II Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 0.6861 mL | 3.4303 mL | 6.8606 mL | 13.7212 mL | 17.1515 mL |
| 5 mM | 0.1372 mL | 0.6861 mL | 1.3721 mL | 2.7442 mL | 3.4303 mL |
| 10 mM | 0.0686 mL | 0.343 mL | 0.6861 mL | 1.3721 mL | 1.7151 mL |
| 50 mM | 0.0137 mL | 0.0686 mL | 0.1372 mL | 0.2744 mL | 0.343 mL |
| 100 mM | 0.0069 mL | 0.0343 mL | 0.0686 mL | 0.1372 mL | 0.1715 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Onjisaponin R
Catalog No.:BCN0882
CAS No.:1008798-85-3
- Onjisaponin W
Catalog No.:BCN0881
CAS No.:1078708-68-5
- Onjisaponin Y
Catalog No.:BCN0880
CAS No.:1078708-71-0
- Arillanin A
Catalog No.:BCN0879
CAS No.:154287-47-5
- Tenuifoliose H
Catalog No.:BCN0878
CAS No.:147742-13-0
- Tenuifoliose A
Catalog No.:BCN0877
CAS No.:139682-01-2
- Tenuifoliose J
Catalog No.:BCN0876
CAS No.:147742-15-2
- Onjisaponin J
Catalog No.:BCN0875
CAS No.:873334-98-6
- Onjisaponin O
Catalog No.:BCN0874
CAS No.:1009314-38-8
- Onjisaponin A
Catalog No.:BCN0873
CAS No.:82410-33-1
- Ginkgolic Acid C17:2
Catalog No.:BCN0872
CAS No.:102811-39-2
- Clinopodiside B
Catalog No.:BCN0871
CAS No.:155762-41-7
- Senegin IV
Catalog No.:BCN0884
CAS No.:51005-46-0
- Parishin D
Catalog No.:BCN0885
CAS No.:952068-64-3
- Cyanidin-3-Xyloside
Catalog No.:BCN0886
CAS No.:29761-24-8
- Cyanidin 3-O-2G-glucosylrutinoside
Catalog No.:BCN0887
CAS No.:55028-57-4
- Cyanidin-3-sophoroside chloride
Catalog No.:BCN0888
CAS No.:38820-68-7
- Delphinidin-3-arabinoside chloride
Catalog No.:BCN0889
CAS No.:27214-74-0
- Delphinidin-3-galactoside chloride
Catalog No.:BCN0890
CAS No.:68852-84-6
- Cinnamtannin A3
Catalog No.:BCN0891
CAS No.:86631-39-2
- Procyanidin A5
Catalog No.:BCN0892
CAS No.:111466-30-9
- Procyanidin A6
Catalog No.:BCN0893
CAS No.:114569-31-2
- Procyanidin A7
Catalog No.:BCN0894
CAS No.:114569-32-3
- Procyanidin B6
Catalog No.:BCN0895
CAS No.:12798-58-2
Anti-angiogenic effect of triterpenoidal saponins from Polygala senega.[Pubmed:21042868]
J Nat Med. 2011 Jan;65(1):149-56.
Senegasaponins [Senegin II (1), Senegin III (2), senegin IV (3), senegasaponin a (4), and senegasaponin b (5)] from Polygala senega were re-discovered as selective anti-proliferative substances against human umbilical vein endothelial cells (HUVECs). Senegasaponins (1-5) showed anti-proliferative activity against HUVECs with IC(50) values in the range 0.6-6.2 muM, and the selective index was 7-100-fold in comparison with those for several cancer cell lines, while the desacyl mixture of senegasaponins (6) and tenuifolin (7) lost anti-proliferative activity, indicating that the 28-O-glycoside moiety and methoxycinnamoyl group were essential for the HUVEC-selective growth inhibition of senegasaponins. Senegin III (2) inhibited the vascular endothelial growth factor (VEGF)-induced in vitro tubular formation of HUVECs and basic fibroblast growth factor (bFGF)-induced in vivo neovascularization in the mouse Matrigel plug assay. Moreover, Senegin III (2) suppressed tumor growth in the ddY mice s.c.-inoculated murine sarcoma S180 cells. The analysis of the action mechanism of Senegin III (2) suggested that the induction of pigment epithelium-derived factor (PEDF) would contribute to the anti-angiogenic effects of senegasaponins.
Studies of the active substances in herbs used for hair treatment. III. Isolation of hair-regrowth substances from Polygara senega var. latifolia TORR. et GRAY.[Pubmed:10598039]
Biol Pharm Bull. 1999 Nov;22(11):1249-50.
Four active principles, 1, 2, 3 and 4, were isolated from Polygara senega var. latifolia TORR. et GRAY by a combination of partition and column chromatography on silica gel and octadecyl silica gel (ODS), monitored by a hair-regrowth activity assay. Compounds 1, 2, 3 and 4 were identified as senegose A, Senegin II, Senegin III, and senegasaponin b by comparison of their spectral data with those of authentic samples.
Mode of action of escins Ia and IIa and E,Z-senegin II on glucose absorption in gastrointestinal tract.[Pubmed:9730238]
Bioorg Med Chem. 1998 Jul;6(7):1019-23.
We examined the mode of action of escins Ia (1) and IIa (2) and E,Z-Senegin II (3) for the inhibitory effect on the increase in serum glucose levels in oral glucose-loaded rats. Although 1-3 inhibited the increase in serum glucose levels in oral glucose-loaded rats, these compounds did not lower serum glucose levels in normal or intraperitoneal glucose-loaded rats, or alloxan-induced diabetic mice. Furthermore, 1-3 suppressed gastric emptying in rats, and also inhibited glucose uptake in the rat small intestine in vitro. These results indicated that 1-3 given orally have neither insulin-like activity nor insulin-releasing activity. Compounds 1-3 inhibited glucose absorption by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting the glucose transport system at the small intestinal brush border.
